A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia on Stable Lipid lowering Therapy.
Periodo
2015 - 2016Tipo de financiación
PrivadaInvestigador principal
Francisco Javier Nóvoa
Investigadores participantes
AM Wägner
Rosa M Sánchez
Rosa M Sánchez
Entidades financiadoras
Aegerion Pharmaceuticals